Golgin A7 anticorps (N-Term)
Aperçu rapide pour Golgin A7 anticorps (N-Term) (ABIN928905)
Antigène
Voir toutes Golgin A7 (GOLGA7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- GOLGA7 antibody was raised in rabbit using the N terminal of GOLGA7 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Golgin A7 (GOLGA7)
-
Autre désignation
- GOLGA7
-
Sujet
- GOLGA7 may be involved in protein transport from Golgi to cell surface. The ZDHHC9-GOLGA7 complex is a palmitoyltransferase specific for HRAS and NRAS. Synonyms: Polyclonal GOLGA7 antibody, Anti-GOLGA7 antibody, golgin A7 antibody, GCP16 antibody, GOLGA3AP1 antibody, HSPC041 antibody, MGC21096 antibody, MGC4876 antibody.
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-